Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page

9. Check if this filing amends a previously filed version of this report

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code AGR

16. Specific lobbying issues

Livestock Cloning/Product Labeling
H.R. 2997/S.1406: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for
FY 2010
2007 Farm Bill Implementation
Livestock Cloning/Product Labeling Cont...
Discussion with EU on Animal Cloning
USTR, USDA & FDA Outreach to European Commission and Parliament

Foreign Agriculture Biotechnology Laws and Regulations
China Biotechnology Bilateral Discussions
Mexico Biotechnology Bilateral Discussions
EU Biotechnology Bilateral Discussions
Canada Biotechnology Bilateral Discussions
APEC Agricultural Biotechnology Discussions
Discussions with EU on Animal Cloning
Vietnam Biotechnology Regulations
Turkish Biotechnology Regulations
Korea Living Modified Organisms Act Revisions
Thailand Biotechnology Regulations
Low-level Presence Foreign Government Policies

U.S. Policy on International Science-Based Regulations

USDA Export Strategy for Agricultural Biotechnology Products

World Trade Organization on EU Biotech Approvals
EU Biotechnology Negotiations

Genetically Engineered (GE) Animals
FDA Final Guidance on Regulation of GE Animals
FDA Approval of First Product From GE Animals

Cartagena Biosafety Protocol
U.S. Government Positions/Activities/Communications at Biosafety Protocol Meetings

USDA/APHIS Agricultural Biotechnology Regulations
USDA Rulemaking on 7CFR 340
USDA Docket on Corn Amylase Petition (No. APHIS-2007-0016)
Efficient Review of Biotech Products
Coexistence of Production Systems

U.S. Policy on Sustainable Agriculture Standard
American National Standards Institute Sustainable Agriculture Standards (ANSI)
International Standards Organization Standard (ISO)

Funding for the USDA
H.R. 2997/S.1406: Agriculture, Rural Development, Food and Drug Administration, and Related Appropriations Act for
FY 2010

Biomass Crop Assistance Program (BCAP)
BCAP Rulemaking and Environmental Impact Statement
2007 Farm Bill Implementation
H.R. 2997/S.1406: Agriculture, Rural Development, Food and Drug Administration, and Related Appropriations Act for
FY 2010
Dedicated Energy Crop Transition
U.S. Government Agriculture Research Funding
H.R. 2997/S.1406: Agriculture, Rural Development, Food and Drug Administration, and Related Appropriations Act for
FY 2010
Agriculture Federal Research Initiative for FY 2009

Global Food Security Initiative
U.S. Government Strategy for Global Food Security

EPA Regulations on Agricultural Biotechnology
Insect Resistance Management
FIFRA Section 7 Regulations
Researcher Access to Patented Products

UN Climate Change Convention
US Government Position on Ag-biotech and Intellectual Property Rights

Biotechnology Stewardship
Biotech Quality Management Stewardship Program

17. House(s) of Congress and Federal agencies Check if None

U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Agriculture - Dept of (USDA), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), State - Dept of (DOS), U.S. Trade Representative (USTR), Office of Science & Technology Policy (OSTP), Office of Management & Budget (OMB),

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code ANI

16. Specific lobbying issues

Genetically Engineered (GE) Animals
FDA Final Guidance on Regulation of GE Animals
FDA Approval of First Product From GE Animals

Livestock Cloning/Product Labeling
H.R. 2997/S.1406: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act
for FY 2010
2007 Farm Bill Implementation
Discussion with EU on Animal Cloning
USTR, USDA & FDA Outreach to European Commission and Parliament

17. House(s) of Congress and Federal agencies Check if None

U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Agriculture - Dept of (USDA), Food & Drug Administration (FDA), Office of Science & Technology Policy (OSTP), U.S. Trade Representative (USTR), State - Dept of (DOS), Office of Management & Budget (OMB),

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code BUD

16. Specific lobbying issues

H.R. 2997/S.1406: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act
for FY 2010
Funding for the Food and Drug Administration (Human Drug Review, Biologics, Food Safety, Critical Path, Reagan-Udall
Foundation, Center for Veterinary Medicine)
H.R. 2997/S.1406: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act
for FY 2010 Cont...
Funding for the USDA: (Office of General Counsel, Biotechnology Regulatory Service (APHIS), Animal Care &
Veterinary Services (APHIS), Trade Activities (Office of the Secretary & Food Safety Inspection Service), Agriculture
Research Service, Biofuels (Rural Development))
Livestock Cloning/Product Labeling
Funding for Biofuels and Bio-based Products
Drug Importation

H.R. 3293: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act
for FY 2010
Funding for National Institutes of Health
Funding for Bioterrorism and Emergency Preparedness
Funding for Pandemic Influenza Preparedness
Funding for Biomedical Advanced Research and Development Authority (BARDA)
Drug Importation

H.R. 3183/S.1436: Energy and Water Development and Related Agencies Appropriations Act for FY 2010
Funding for Biofuels and Bio-based Products

H.R. 3081/S.1434: Department of State, Foreign Operations and Related Programs Appropriations Act for FY 2010
Funding for Biotechnology Research and Development Programs at the Agency for International Development

H.R. 2996: Department of the Interior, Environment, and Related Agencies Appropriations Act for FY 2010
Funding for Bio-based Products
Climate Change/Indirect Land Use

H.R. 2892: Department of Homeland Security Appropriations Act for FY 2010
Drug Importation

H.R. 3288: Consolidated Appropriations Act for FY 2010
Funding for National Institutes of Health
Funding for Bioterrorism and Emergency Preparedness
Funding for Pandemic Influenza Preparedness
Funding for Biotechnology Research and Development Programs at the Agency for International Development

17. House(s) of Congress and Federal agencies Check if None

U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Food & Drug Administration (FDA), Natl Security Council (NSC)

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code CAW

16. Specific lobbying issues

Climate Change Benefits of Biofuels and Bio-based Products
H.R. 2454: American Clean Energy and Security Act of 2009
S. 1733: Clean Energy Jobs and American Power Act of 2009
U.S. Government Position for U.N. Convention on Climate Change Negotiations
Climate Change Benefits of Biofuels and Bio-based Products Cont...
Bio-based Products Tax Credit

IP Rights for Environmental Technologies
U.S. Government Position for U.N. Convention on Climate Change Negotiations

Climate Change/Indirect Land Use
H.R. 2996: Department of the Interior, Environment, and Related Agencies Appropriations Act for 2010
H.R. 2454: American Clean Energy and Security Act of 2009
S.1733: Clean Energy Jobs and American Power Act of 2009

17. House(s) of Congress and Federal agencies Check if None

U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Agriculture - Dept of (USDA), State - Dept of (DOS), U.S. Trade Representative (USTR), Environmental Protection Agency (EPA)

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code CPT

16. Specific lobbying issues

Patent Reform
H.R. 1260: The Patent Reform Act of 2009
S. 515. The Patent Reform Act of 2009
S.610: The Patent Reform Act of 2009
World Trade Organization Special 301 Submissions

Convention on Biological Diversity Patent Disclosure Requirements

Gene Patenting
Proposed Legislation by Rep. Wasserman Schultz
Genomic Research and Accessibility Act
Bayh-Dole Act/Tech Transfer
HHS Secretary's Advisory Committee Report

IP Rights for Environmental Technologies
U.S. Government Position for U.N. Convention on Climate Change Negotiations

17. House(s) of Congress and Federal agencies Check if None

U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, State - Dept of (DOS), U.S. Trade Representative (USTR), Patent & Trademark Office (PTO),

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code CSP

16. Specific lobbying issues

Genetically Engineered (GE) Animals
FDA Final Guidance on Regulation of GE Animals
FDA Approval of First Product From GE Animals

Funding for the Food and Drug Administration
H.R. 2997/S.1406: Agriculture, Rural Development, Food and Drug Administration, and Related agencies
Appropriations Act for FY 2010

Reporting of Physician Payments
S.310: Physician Payments Sunshine Act of 2009
H.R. 3200: America's Affordable Health Choices Act
H.R. 3590: (Senate) Patient Protection and Affordable Care Act
H.R. 3962: Affordable Health Care for America Act

Drug Safety and Review
H.R. 759: FDA Globalization Act of 2009
S. 882: Drugs and Device Accountability Act of 2009
H.R. 2749: Food Safety Enhancement Act of 2009
Critical Path
FDA Regulatory Transparency

Drug Importation
S.525: Pharmaceutical Market Access and Drug Safety Act of 2009
H.R. 2997/S.1406: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies
Appropriations Act for FY 2010
H.R. 3293: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act
for FY 2010
H.R. 2892: Department of Homeland Security Appropriations Act for FY 2010
S.1232: Pharmaceutical Market Access Act of 2009
S.80: Pharmaceutical Market Access Act of 2009
H.R. 1298: Pharmaceutical Market Access and Drug Safety Act of 2009
H.R. 3590: (Senate) Patient Protection and Affordable Care Act

Livestock Cloning/Product Labeling
H.R. 2997/S.1406: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies
Appropriations Act for FY 2010
2007 Farm Bill Implementation
Discussion with EU on Animal Cloning
USTR, USDA & FDA Outreach to European Commission and Parliament

USDA/APHIS Agricultural Biotechnology Regulations
USDA Rulemaking on 7CFR 340
USDA Docket on Corn Amylase Petition (No. APHIS-2007-0016)
Efficient Review of Biotech Products
Coexistence of Production Systems

17. House(s) of Congress and Federal agencies Check if None

U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Agriculture - Dept of (USDA), Food & Drug Administration (FDA), U.S. Trade Representative (USTR), Office of Science & Technology Policy (OSTP), Office of Management & Budget (OMB), Environmental Protection Agency (EPA),

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code ENG

16. Specific lobbying issues

Renewable Fuels Standard
EPA Rulemaking on Life-cycle Greenhouse Gas Emissions Requirements
Implementation of Energy Independence and Security Act of 2007
EPA Petition to Raise the Ethanol Blend Wall to 15%
Algae-based Renewable Fuel/Carbon Capture and Conversion
S.1013: Department of Energy Carbon Capture and Sequestration Program Amendments Act of 2009
S.1250: Algae-based Renewable Fuel Promotion Act of 2009
H.R. 4168: Algae-based Renewable Fuel Promotion Act of 2009
Cellulosic Tax Credit Modification for Algae-based Biofuels

Biofuels
H.R. 3183/S.1436: Energy and Water Development and Related Agencies Appropriations Act for FY 2010
H.R. 2997/S.1406: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies
Appropriations Act for FY 2010
H.R. 2996: Department of the Interior, Environment, and Related Agencies Appropriations Act for FY 2010
Loan Guarantees and Grants under S.1: American Recovery and Reinvestment Act

Bio-based Products
H.R. 3183/S.1436: Energy and Water Development and Related Agencies Appropriations Act for FY 2010
H.R. 2996: Department of the Interior, Environment, and Related Agencies Appropriations Act for FY 2010
H.R. 2997/S.1406: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies
Appropriations Act for FY 2010
BioPreferred Program Implementation under 2007 Farm Bill
Tax Credit

Climate Change Benefits of Biofuels and Bio-based Products
H.R. 2454: American Clean Energy and Security Act of 2009
S. 1733: Clean Energy Jobs and American Power Act of 2009
U.S. Government Position for U.N. Convention on Climate Change Negotiations
Bio-based Product Tax Credit

17. House(s) of Congress and Federal agencies Check if None

U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Agriculture - Dept of (USDA), Environmental Protection Agency (EPA), Energy - Dept of,

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code FOO

16. Specific lobbying issues

Genetically Engineered (GE) Animals
FDA Final Guidance on Regulation of GE Animals
FDA Approval of First Product From GE Animals

Livestock Cloning/Product Labeling
H.R. 2997/S.1406: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act
for FY 2010
2007 Farm Bill Implementation
Discussion with EU on Animal Cloning
USTR, USDA & FDA Outreach to European Commission and Parliament

Global Food Security Initiative
U.S. Government Strategy for Global Food Security

17. House(s) of Congress and Federal agencies Check if None

U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Agriculture - Dept of (USDA), Food & Drug Administration (FDA), U.S. Trade Representative (USTR), Office of Science & Technology Policy (OSTP), State - Dept of (DOS), Office of Management & Budget (OMB),

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code FUE

16. Specific lobbying issues

Renewable Fuels Standard
EPA Rulemaking on Life-cycle Greenhouse Gas Emissions Requirements
Implementation of Energy Independence and Security Act of 2007
EPA Petition to Raise the Ethanol Blend Wall to 15%
Algae-based Renewable Fuel/Carbon Capture and Conversion
S.1013: Department of Energy Carbon Capture and Sequestration Program Amendments Act of 2009
S.1250: Algae-based Renewable Fuel Promotion Act of 2009
H.R. 4168: Algae-based Renewable Fuel Promotion Act of 2009
Cellulosic Tax Credit Modification for Algae-based Biofuels

Biofuels
H.R. 3183/S.1436: Energy and Water Development and Related Agencies Appropriations Act for FY 2010
H.R. 2997/S.1406: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies
Appropriations Act for FY 2010
H.R. 2996: Department of the Interior, Environment, and Related Agencies Appropriations Act for FY 2010
Loan Guarantees and Grants under S.1: American Recovery and Reinvestment Act

Bio-based Products
H.R. 3183/S.1436: Energy and Water Development and Related Agencies Appropriations Act for FY 2010
H.R. 2996: Department of the Interior, Environment, and Related Agencies Appropriations Act for FY 2010
H.R. 2997/S.1406: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies
Appropriations Act for FY 2010
BioPreferred Program Implementation under 2007 Farm Bill
Tax Credit

Climate Change Benefits of Biofuels and Bio-based Products
H.R. 2454: American Clean Energy and Security Act of 2009
S. 1733: Clean Energy Jobs and American Power Act of 2009
U.S. Government Position for U.N. Convention on Climate Change Negotiations
Bio-based Product Tax Credit

17. House(s) of Congress and Federal agencies Check if None

U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Environmental Protection Agency (EPA), Agriculture - Dept of (USDA), Energy - Dept of,

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code HCR

16. Specific lobbying issues

Healthcare Reform
Comparative Effectiveness Research Program Initiatives
In Vitro Diagnostics Regulatory Oversight
Vaccine Access/Financing
Health Care Reform Cont...
Follow-on Biologics
Reporting of Physician Payments
Expansion of 340B Drug Pricing Program
Generic Fill Incentives
Therapeutic Discovery Project Tax Credit
Pharmaceutical Excise Tax
Medicaid Rebates
Dual Eligibles
H.R. 3590: (Senate) Patient Protection and Affordable Care Act
H.R. 3962: Affordable Health Care for America Act
H.R. 3200: America's Affordable Health Choices Act of 2009
S. 1679: Affordable Health Choices Act of 2009
S.1796: America's Healthy Future Act of 2009


Drug Safety and Review
H.R. 759: FDA Globalization Act of 2009
S. 882: Drugs and Device Accountability Act of 2009
H.R. 2749: Food Safety Enhancement Act of 2009
Critical Path
FDA Regulatory Transparency

Drug Importation
S.525: Pharmaceutical Market Access and Drug Safety Act of 2009
H.R. 2997/S.1406: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies
Appropriations Act for FY 2010
H.R. 3293: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act
for FY 2010
H.R. 2892: Department of Homeland Security Appropriations Act for FY 2010
S.1232: Pharmaceutical Market Access Act of 2009
S.80: Pharmaceutical Market Access Act of 2009
H.R. 1298: Pharmaceutical Market Access and Drug Safety Act of 2009
H.R. 3590: (Senate) Patient Protection and Affordable Care Act

Funding for the Food and Drug Administration
H.R. 2997?S.1406: Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations
Act for FY 2010

Stem Cell Research

Medicaid Rebates
S.1796: America's Healthy Future Act of 2009
S.1679: Affordable Health Choices Act of 2009
H.R. 3200: America's Affordable Health Choices Act
H.R. 3590: (Senate) Patient Protection and Affordable Care Act
H.R. 3962: Affordable Health Care for America Act
Dual Eligibles

Generic Fill Incentives
H.R. 3590: (Senate) Patient Protection and Affordable Care Act
H.R. 3962: Affordable Health Care for America Act

Funding for Biomedical Advanced Research & Development Authority (BARDA)
H.R. 3293: Departments of Labor, Health and Human Services and Education, and Related Agencies Appropriations Act
for FY 2010
H.R. 3288: Consolidated Appropriations Act for FY 2010

In Vitro Diagnostics
Regulatory Oversight
H.R. 3200: America's Affordable Health Choices Act
S.1679: Affordable Health Choices Act of 2009
S.1796: America's Healthy Future Act of 2009
H.R. 3590: (Senate) Patient Protection and Affordable Care Act
H.R. 3962: Affordable Health Care for America Act

Comparative Effectiveness Program Initiatives
S.1213: Patient-Centered Outcomes Research Act of 2009
H.R. 2502: Comparative Effectiveness Research Act of 2009
H.R. 2824: Doctor-Patient Relationship and Research Protection Act
S.1796: America's Healthy Future Act of 2009
S.1679: Affordable Health Choices Act of 2009
H.R. 3200: America's Affordable Health Choices Act
H.R. 3590: (Senate) Patient Protection and Affordable Care Act
H.R. 3962: Affordable Health Care for America Act

Funding for National Institutes of Health
H.R. 3293: Departments of Labor, Health and Human Services and Education, and Related Agencies Appropriations Act
for FY 2010
H.R. 3288: Consolidated Appropriations Act for FY 2010

Funding for Bioterrorism and Emergency Preparedness
H.R. 3293: Departments of Labor, Health and Human Services and Education, and Related Agencies Appropriations Act
for FY 2010
H.R. 3288: Consolidated Appropriations Act for FY 2010

Funding for Pandemic Influenza Preparedness
H.R. 3293: Departments of Labor, Health and Human Services and Education, and Related Agencies Appropriations Act
for FY 2010
H.R. 3288: Consolidated Appropriations Act for FY 2010

Reporting of Physician Payments
S. 310: Physician Payments Sunshine Act of 2009
H.R. 3200: America's Affordable Health Choices Act
H.R. 3590: (Senate) Patient Protection and Affordable Care Act
H.R. 3962: Affordable Health Care for America Act

Vaccine Access/Financing
S.1796:America's Healthy Future Act of 2009
S.1679: America's Affordable Health Choices Act of 2009
H.R. 3200: America's Affordable Health Choices Act
H.R. 3590: (Senate) Patient Protection and Affordable Care Act
H.R. 3962: Affordable Health Care for America Act
S. 2868: Federal Supply Scheduels Usage Act of 2009
S.1649: Weapons of Mass Destruction Preparedness Act of 2009
Expansion of 340B Drug Pricing Program
S.1796:America's Healthy Future Act of 2009
S.1679: Affordable Health Choices Act of 2009
H.R. 3200: America's Affordable Health Choices Act
H.R. 3590: (Senate) Patient Protection and Affordable Care Act
H.R. 3962: Affordable Health Care for America Act

Federal Supply Schedule Access
S.2868: Federal Supply Schedules Usage Act of 2009

Follow-on Biologics
H.R. 1427: Promoting Innovation and Access to Life-Saving Medicines Act
H.R. 1548: Pathway for Biosimilars Act of 2009
S. 726: Promoting Innovation and Access to Life-Saving Medicine Act
H.R. 3200: America's Affordable Health Choices Act
S.1679: Affordable Health Choices Act of 2009
S.1796: America's Healthy Future Act of 2009
H.R. 3590: (Senate) Patient Protection and Affordable Care Act
H.R. 3962: Affordable Health Care for America Act
Reimbursement Issues

17. House(s) of Congress and Federal agencies Check if None

U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Food & Drug Administration (FDA), Treasury - Dept of, Natl Security Council (NSC),

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code HOM

16. Specific lobbying issues

Funding for Pandemic Influenza Preparedness
H.R. 3293: Departments of Labor, Health and Human Services and Education, and Related Agencies Appropriations Act for
FY 2010
H.R. 3288: Consolidated Appropriations Act for FY 2010
Funding for Biomedical Advanced Research & Development Authority (BARDA)
H.R. 3293: Departments of Labor, Health and Human Services and Education, and Related Agencies Appropriations Act
for FY 2010
H.R. 3288: Consolidated Appropriations Act for FY 2010

Funding for Bioterrorism and Emergency Preparedness
H.R. 3293: Departments of Labor, Health and Human Services and Education, and Related Agencies Appropriations Act
for FY 2010
H.R. 3288: Consolidated Appropriations Act for FY 2010

Enhanced Security Regulations at Biodefense Labs
S.1649: Weapons of Mass Destruction Prevention and Preparedness Act of 2009

Managing Risks of Misues of the Life Sciences
National Strategy for Countering Biological Threats

Federal Supply Schedule Access During Emergencies
S. 2868: Federal Supply Schedules Usage Act of 2009

17. House(s) of Congress and Federal agencies Check if None

U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Natl Security Council (NSC)

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code MED

16. Specific lobbying issues

Funding for Bioterrorism and Emergency Preparedness
H.R. 3293: Departments of Labor, Health and Human Services and Education, and Related Agencies Appropriations Act for
FY 2010
H.R. 3288: Consolidated Appropriations Act for FY 2010
Funding for National Institutes of Health
H.R. 3293: Departments of Labor, Health and Human Services and Education, and Related Agencies Appropriations Act
for FY 2010
H.R. 3288: Consolidated Appropriations Act for FY 2010

Funding for Biomedical Advanced Research & Development Authority (BARDA)
H.R. 3293: Departments of Labor, Health and Human Services and Education, and Related Agencies Appropriations Act
for FY 2010
H.R. 3288: Consolidated Appropriations Act for FY 2010

Funding for the Food and Drug Administration
H.R. 2997/S.1406: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies
Appropriations Act for FY 2010

Funding for Pandemic Influenza Preparedness
H.R. 3293: Departments of Labor, Health and Human Services and Education, and Related Agencies Appropriations Act
for FY 2010
H.R. 3288: Consolidated Appropriations Act for FY 2010

In Vitro Diagnostics
Regulatory Oversight
H.R. 3200: America's Affordable Health Choices Act
S.1679: Affordable Health Choices Act of 2009
S. 1769: America's Healthy Future Act of 2009
H.R. 3590: (Senate) Patient Protection and Affordable Care Act
H.R. 3962: Affordable Health Care for America Act

Stem Cell Research

Comparative Effectiveness Program Initiatives
H.R. 2502: Comparative Effectiveness Research Act of 2009
H.R. 2824: Doctor-Patient Relationship and Research Protection Act
S. 1679: America's Healthy Future Act of 2009
S. 1213: Patient-Centered Outcomes Research Act of 2009
S.1679: Affordable Health Choices Act of 2009
H.R. 3200: America's Affordable Health Choices Act
H.R. 3590: (Senate) Patient Protection and Affordable Care Act
H.R. 3962: Affordable Health Care for America Act

17. House(s) of Congress and Federal agencies Check if None

U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Food & Drug Administration (FDA), Natl Security Council (NSC),

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code MMM

16. Specific lobbying issues

Medicaid Rebates
H.R. 3200: America's Affordable Health Choices Act
S.1679: America's Affordable Health Choices Act of 2009
S.1796: America's Healthy Future Act of 2009
Medicaid Rebates Cont...
H.R. 3590: (Senate) Patient Protection and Affordable Care Act
H.R. 3962: Affordable Health Care for America Act
Dual Eligibles

Reimbursement for Follow-on Biologics
H.R. 3590: (Senate) Patient Protection and Affordable Care Act
H.R. 3962: Affordable Health Care for America Act
S.1796: America's Healthy Future Act of 2009

17. House(s) of Congress and Federal agencies Check if None

U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code SCI

16. Specific lobbying issues

Small Business Innovation and Research (SBIR) Program Reauthorization
H.R. 2965/S.1233: Enhancing Small Business Research and Innovation Act of 2009

Biotech Innovation/R&D Initiatives
Research & Development Tax Credit Extension
H.R. 4213: Tax Extenders Act of 2009

Stem Cell Research

17. House(s) of Congress and Federal agencies Check if None

U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Small Business Adminstration (SBA), Office of Science & Technology Policy (OSTP)

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code SMB

16. Specific lobbying issues

Small Business Innovation and Research (SBIR) Program Reauthorization
H.R. 2965/S.1233: Enhancing Small Business Research and Innovation Act of 2009

SBA Grant Proposal for Early Stage Investment
H.R. 3738: Small Business Early-Stage Investment Act of 2009
H.R. 3854: Small Business Financing and Investment Act of 2009

Therapeutic Discovery Project Tax Credit
S.1796: America's Healthy Future Act of 2009
H.R. 3590: (Senate) Patient Protection and Affordable Care Act
H.R. 3200: America's Affordable Health Choices Act of 2009
H.R. 3962: Affordable Health Care for America Act

Small Business Definition in SEC Rule 12b-2
H.R. 4173: Wall Street Reform and Consumer Protection Act of 2009

Sarbanes Oxley Section 404 (b) Exemption
H.R. 4173: Wall Street Reform and Consumer Protection Act of 2009

17. House(s) of Congress and Federal agencies Check if None

U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Small Business Adminstration (SBA), Securities & Exchange Commission (SEC), Treasury - Dept of,

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code TAX

16. Specific lobbying issues

Therapeutic Discovery Project Tax Credit
S.1796: America's Healthy Future Act of 2009
H.R. 3590: (Senate) Patient Protection and Affordable Care Act
H.R. 3962: Affordable Health Care for America Act
Therapeutic Discovery Project Tax Credit Cont...
H.R. 3200: America's Affordable Health Choices Act

Bio-based Products
Tax Credits
H.R. 2454: American Clean Energy and Security Act of 2009
S. 1733: Clean Energy Jobs and American Power Act of 2009

Pharmaceutical Excise Tax
S.1796: America's Healthy Future Act of 2009
H.R. 3590: (Senate) Patient Protection and Affordable Care Act

Research and Development Tax Credit Extension
H.R. 4213: Tax Extenders Act of 2009

Cellulosic Tax Credit Modification for Algae-based Biofuels
S.1250: Algae-based Renewable Fuel Promotion Act of 2009

17. House(s) of Congress and Federal agencies Check if None

U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Treasury - Dept of

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code TRD

16. Specific lobbying issues

Cartagena Biosafety Protocol
U.S. Government Positions/Activities/Communications at Biosafety Protocol Meetings

Foreign Agriculture Biotechnology Laws and Regulations
China Biotechnology Bilateral Discussions
Mexico Biotechnology Bilateral Discussions
EU Biotechnology Bilateral Discussions
Canada Biotechnology Bilateral Discussions
APEC Agricultural Biotechnology Discussions
Discussions with EU on Animal Cloning
Vietnam Biotechnology Regulations
Turkish Biotechnology Regulations
Korea Living Modified Organisms Act Revisions
Thailand Biotechnology Regulations
Low-level Presence Foreign Government Policies

U.S. Policy on International Science-Based Regulations

USDA Export Strategy for Agricultural Biotechnology Products

World Trade Organization Special 301 Submissions

World Trade Organization on EU Biotech Approvals
EU Biotechnology Negotiations

Drug Importation
S.525: Pharmaceutical Market Access and Drug Safety Act of 2009
H.R. 2997/S.1406: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies
Appropriations Act for FY 2010
H.R. 3293: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act
for FY 2010
H.R. 2892: Department of Homeland Security Appropriations Act for FY 2010
S. 1213: Patient-Centered Outcomes Research Act of 2009
S.1232: Pharmaceutical Market Access Act of 2009
S.80: Pharmaceutical Market Access Act of 2009
H.R. 1298: Pharmaceutical Market Access and Drug Safety Act of 2009
H.R. 3590: (Senate) Patient Protection and Affordable Care Act

Livestock Cloning/Product Labeling
Discussion with EU on Animal Cloning
USTR, USDA & FDA Outreach to European Commission and Parliament

17. House(s) of Congress and Federal agencies Check if None

U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Commerce - Dept of (DOC), Agriculture - Dept of (USDA), State - Dept of (DOS), U.S. Trade Representative (USTR),

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code PHA

16. Specific lobbying issues

Medicaid Rebates
H.R. 3200: America's Affordable Health Choices Act
S.1679: Affordable Health Choices Act of 2009
S.1796: America's Healthy Future Act of 2009
Medicaid Rebates Cont...
H.R. 3590: (Senate) Patient Protection and Affordable Care Act
H.R. 3962: Affordable Health Care for America Act
Dual Eligibles

Comparative Effectiveness Program Initiatives
H.R. 2502: Comparative Effectiveness Research Act of 2009
H.R. 2824: Doctor-Patient Relationship and Research Protection Act
S. 1796: America's Healthy Future Act of 2009
S. 1213: Patient-Centered Outcomes Research Act of 2009
S.1679: Affordable Health Choices Act of 2009
H.R. 3200: America's Affordable Health Choices Act
H.R. 3590: (Senate) Patient Protection and Affordable Care Act
H.R. 3962: Affordable Health Care for America Act

Drug Importation
S.525: Pharmaceutical Market Access and Drug Safety Act of 2009
H.R. 2997/S.1406: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies
Appropriations Act for FY 2010
H.R. 3293: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act
for FY 2010
H.R. 2892: Department of Homeland Security Appropriations Act for FY 2010
S.1232: Pharmaceutical Market Access Act of 2009
S.80: Pharmaceutical Market Access Act of 2009
H.R. 1298: Pharmaceutical Market Access and Drug Safety Act of 2009
H.R. 3590: (Senate) Patient Protection and Affordable Care Act

Drug Safety and Review
H.R. 759: FDA Globalization Act of 2009
S. 882: Drugs and Device Accountability Act of 2009
H.R. 2749: Food Safety Enhancement Act of 2009
Critical Path
FDA Regulatory Transparency

Generic Fill Incentives
H.R. 3590: (Senate) Patient Protection and Affordable Care Act
H.R. 3962: Affordable Health Care for America Act

17. House(s) of Congress and Federal agencies Check if None

U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Food & Drug Administration (FDA),

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

Information Update Page - Complete ONLY where registration information has changed.

20. Client new address

21. Client new principal place of business (if different than line 20)

22. New General description of client’s business or activities

LOBBYIST UPDATE

23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client

ISSUE UPDATE

24. General lobbying issue that no longer pertains

AFFILIATED ORGANIZATIONS

25. Add the following affiliated organization(s)

Internet Address: BIO maintains a list of all of its members on its website at http://bio.org/membership/index.asp

26. Name of each previously reported organization that is no longer affiliated with the registrant or client

FOREIGN ENTITIES

27. Add the following foreign entities:

28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization